Structure via PubChem · Public domain (PubChem)
diphenylpyraline
Sign in to saveAlso known as diphenylpyralamine, 4-(benzhydryloxy)-N-methylpiperidine, 1-methyl-4-hydroxypiperidine benzhydryl ether, 4-(benzhydryloxy)-1-methylpiperidine, 1-methyl-4-piperidyl benzhydryl ether
Diphenylpyraline (DPP; sold as Allergen, Arbid, Belfene, Diafen, Hispril, Histyn, Lergobine, Lyssipol, Mepiben, Neargal) is a first-generation antihistamine with anticholinergic effects of the diphenylpiperidine class. It is marketed in Europe for the treatment of allergies. DPP has also been found to act as a dopamine reuptake inhibitor and produces hyperactivity in rodents. It has been shown to be useful in the treatment of Parkinsonism.
In the Vinony graph
Vinony's link graph records 1,089 inbound references to diphenylpyraline, and connects out to atropine, Anatomical Therapeutic Chemical Classification System and histamine antagonist.
It sits within the topics Diphenylmethanol ethers, Drugs with non-standard legal status and ECHA InfoCard ID from Wikidata.
Vinony links it to 10 Wikipedia language editions.
Chemical data
- Formula
- C19H23NO
- Molecular weight
- 281.4 g/mol
- IUPAC name
- 4-benzhydryloxy-1-methylpiperidine
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 1982
- Admin. routes
- oral
- Indications
- allergic disease
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 281.178
- Has use
- medication
Show 5 more facts
- chemical formula
- C₁₉H₂₃NO
- canonical SMILES
- CN1CCC(CC1)OC(C2=CC=CC=C2)C3=CC=CC=C3
- World Health Organisation international non-proprietary name
- diphenylpyraline
- defined daily dose
- 10.0
- Commons category
- Diphenylpyraline
Sources (3)
via Wikidata · CC0
~1 min read
Encyclopedic overview
3 sectionsContents
- Synthesis
- See also
- References
Diphenylpyraline (DPP; sold as Allergen, Arbid, Belfene, Diafen, Hispril, Histyn, Lergobine, Lyssipol, Mepiben, Neargal) is a first-generation antihistamine with anticholinergic effects of the diphenylpiperidine class. It is marketed in Europe for the treatment of allergies. DPP has also been found to act as a dopamine reuptake inhibitor and produces hyperactivity in rodents. It has been shown to be useful in the treatment of Parkinsonism.
==Synthesis== 501px|center|class=skin-invert-image
Excerpted from Wikipedia’s “diphenylpyraline” article, available under the CC BY-SA 4.0 licence.
Gallery (2)
Available in 10 languages
via Wikidata sitelinks · CC0